2013 glutathione parkinson's disease four authors Chemically Induced Models of Disease: History and Perspectives for the Involvement of Ferroptosis Parkinson's Disease: Current Treatment Modalities

Early haematological response begins with reticulocytosis (increased production of immature red blood cells) typically by day 3-4 of treatment , particularly with injectable forms, though the full resolution of symptoms may take several weeks to months

Nature 513 , 559563 (2014)

The highest TAC activity in the liver was observed in the group treated with Cu-NPs, followed by those injected with ZnO-NPs and Fe 3 O 4 -NPs, with increases of 41.30, 40.44, and 30.87%, respectively, compared with the control group

While we always personalize treatment, heres a general starting point we use when creating a plan: Dosage: 250 to 500 mcg per day Method: Subcutaneous injection near the affected joint Cycle: 4 weeks on, followed by 2 to 4 weeks off Duration: Usually 1 to 3 cycles, depending on severity Injectable BPC-157 is preferred for arthritis